{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:32:25Z","timestamp":1793298745723,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tongji University Medicine-X Interdisciplinary Research Initiative","award":["2025-0554-YB-04"],"award-info":[{"award-number":["2025-0554-YB-04"]}]},{"name":"Tongji University Medicine-X Interdisciplinary Research Initiative","award":["2025-0554-YB-03"],"award-info":[{"award-number":["2025-0554-YB-03"]}]},{"name":"Natural Science Foundation of Shanghai","award":["22ZR1452300"],"award-info":[{"award-number":["22ZR1452300"]}]},{"name":"Natural Science Foundation of Shanghai","award":["20ZR1446800"],"award-info":[{"award-number":["20ZR1446800"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82000068"],"award-info":[{"award-number":["82000068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270064"],"award-info":[{"award-number":["82270064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100073"],"award-info":[{"award-number":["82100073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2024YFA1108900"],"award-info":[{"award-number":["2024YFA1108900"]}]},{"name":"Clinical Research Youth Project of Shanghai Health Commission","award":["20234Y0275"],"award-info":[{"award-number":["20234Y0275"]}]},{"name":"Shanghai Pulmonary Hospital Project Newcomer Program","award":["Fkxr2304"],"award-info":[{"award-number":["Fkxr2304"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03863-y","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T11:41:13Z","timestamp":1754134873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum metabolomics in pulmonary sarcoidosis: metabolic signatures across prognoses"],"prefix":"10.1186","volume":"25","author":[{"given":"Dafu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"3863_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/joim.13629","volume":"293","author":"M Rossides","year":"2023","unstructured":"Rossides M, Darlington P, Kullberg S, Arkema EV. Sarcoidosis: epidemiology and clinical insights. J Intern Med. 2023;293:668\u201380.","journal-title":"J Intern Med"},{"key":"3863_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jama.2022.1570","volume":"327","author":"JA Belperio","year":"2022","unstructured":"Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R, Lynch JP. Diagnosis and treatment of pulmonary sarcoidosis: a review. JAMA. 2022;327:856\u201367.","journal-title":"JAMA"},{"key":"3863_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155\u201367.","journal-title":"Lancet"},{"key":"3863_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1744666X.2019.1568240","volume":"15","author":"M Ramos-Casals","year":"2019","unstructured":"Ramos-Casals M, Retamozo S, Siso-Almirall A, Perez-Alvarez R, Pallares L, Brito-Zeron P. Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert Rev Clin Immunol. 2019;15:391\u2013405.","journal-title":"Expert Rev Clin Immunol"},{"key":"3863_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01443","volume":"11","author":"R Kraaijvanger","year":"2020","unstructured":"Kraaijvanger R, Janssen Bonas M, Vorselaars ADM, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020;11: 1443.","journal-title":"Front Immunol"},{"key":"3863_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14070709","author":"M Della Zoppa","year":"2024","unstructured":"Della Zoppa M, Bertuccio FR, Campo I, Tousa F, Crescenzi M, Lettieri S, Mariani F, Corsico AG, Piloni D, Stella GM. Phenotypes and serum biomarkers in sarcoidosis. Diagnostics. 2024. https:\/\/doi.org\/10.3390\/diagnostics14070709.","journal-title":"Diagnostics"},{"key":"3863_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/MCP.0000000000000306","volume":"22","author":"A Carleo","year":"2016","unstructured":"Carleo A, Bennett D, Rottoli P. Biomarkers in sarcoidosis: the contribution of system biology. Curr Opin Pulm Med. 2016;22:509\u201314.","journal-title":"Curr Opin Pulm Med"},{"key":"3863_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12026-020-09158-0","volume":"68","author":"L Bergantini","year":"2020","unstructured":"Bergantini L, d\u2019Alessandro M, Vietri L, Rana GD, Cameli P, Acerra S, Sestini P, Bargagli E. Utility of serological biomarker\u2019 panels for diagnostic accuracy of interstitial lung diseases. Immunol Res. 2020;68:414\u201321.","journal-title":"Immunol Res"},{"key":"3863_CR9","doi-asserted-by":"publisher","first-page":"C1336","DOI":"10.1152\/ajpcell.00316.2023","volume":"325","author":"J Kim","year":"2023","unstructured":"Kim J, Lee S, Moodley Y, Yagnik L, Birnie D, Dwivedi G. The role of the host-microbiome and metabolomics in sarcoidosis. Am J Physiol Cell Physiol. 2023;325:C1336-53.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3863_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-015-0932-2","author":"A Geamanu","year":"2016","unstructured":"Geamanu A, Gupta SV, Bauerfeld C, Samavati L. Metabolomics connects aberrant bioenergetic, transmethylation, and gut microbiota in sarcoidosis. Metabolomics. 2016. https:\/\/doi.org\/10.1007\/s11306-015-0932-2.","journal-title":"Metabolomics"},{"key":"3863_CR11","doi-asserted-by":"publisher","first-page":"19584","DOI":"10.1038\/s41598-019-56174-8","volume":"9","author":"MM Banoei","year":"2019","unstructured":"Banoei MM, Iupe I, Bazaz RD, Campos M, Vogel HJ, Winston BW, Mirsaeidi M. Metabolomic and metallomic profile differences between veterans and civilians with pulmonary sarcoidosis. Sci Rep. 2019;9:19584.","journal-title":"Sci Rep"},{"key":"3863_CR12","first-page":"10","volume":"33","author":"B Duchemann","year":"2016","unstructured":"Duchemann B, Triba MN, Guez D, Rzeznik M, Savarin P, Nunes H, Valeyre D, Bernaudin JF, Le Moyec L. Nuclear magnetic resonance spectroscopic analysis of salivary metabolome in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33:10\u20136.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"3863_CR13","doi-asserted-by":"crossref","unstructured":"Shimizu H, Usui Y, Asakage M, Nezu N, Wakita R, Tsubota K, Sugimoto M, Goto H. Serum metabolomic profiling of patients with Non-Infectious uveitis. J Clin Med 2020;9:3955. https:\/\/www.mdpi.com\/2077-0383\/9\/12\/3955.","DOI":"10.3390\/jcm9123955"},{"key":"3863_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-023-02052-4","volume":"19","author":"MK Rai","year":"2023","unstructured":"Rai MK, Yadav S, Jain A, Singh K, Kumar A, Raj R, Dubey D, Singh H, Guleria A, Chaturvedi S, et al. Clinical metabolomics by NMR revealed serum metabolic signatures for differentiating sarcoidosis from tuberculosis. Metabolomics. 2023;19: 92.","journal-title":"Metabolomics"},{"key":"3863_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1342429","volume":"14","author":"HL Ji","year":"2023","unstructured":"Ji HL, Xi NMS, Mohan C, Yan X, Jain KG, Zang QS, Gahtan V, Zhao R. Biomarkers and molecular endotypes of sarcoidosis: lessons from omics and non-omics studies. Front Immunol. 2023;14: 1342429.","journal-title":"Front Immunol"},{"key":"3863_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/mas.21445","volume":"35","author":"DQ Tang","year":"2016","unstructured":"Tang DQ, Zou L, Yin XX, Ong CN. HILIC-MS for metabolomics: an attractive and complementary approach to RPLC-MS. Mass Spectrom Rev. 2016;35:574\u2013600.","journal-title":"Mass Spectrom Rev"},{"key":"3863_CR17","doi-asserted-by":"crossref","unstructured":"Ma B, Samavati L, Drake WP. Sarcoidosis resolvers and progressors demonstrate distinct systemic metabolomic profiles. bioRxiv. 2025.","DOI":"10.1101\/2025.03.10.642370"},{"key":"3863_CR18","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, et al. Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e26\u201351.","journal-title":"Am J Respir Crit Care Med"},{"key":"3863_CR19","first-page":"93","volume":"25","author":"Y Zhou","year":"2008","unstructured":"Zhou Y, Li HP, Li QH, Zheng H, Zhang RX, Chen G, Baughman RP. Differentiation of sarcoidosis from tuberculosis using real-time PCR assay for the detection and quantification of Mycobacterium tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:93\u20139.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"3863_CR20","first-page":"11","volume":"29","author":"QH Li","year":"2012","unstructured":"Li QH, Li HP, Shen YP, Zhao L, Shen L, Zhang Y, Jiang DH, Baughman RP. A novel multi-parameter scoring system for distinguishing sarcoidosis from sputum negative tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29:11\u20138.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"3863_CR21","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang Z, Lu Y, Zhou G, Hui F, Xu L, Viau C, Spigelman AF, MacDonald PE, Wishart DS, Li S, Xia J. Metaboanalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024;52:W398-406.","journal-title":"Nucleic Acids Res"},{"key":"3863_CR22","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1164\/rccm.202307-1273OC","volume":"209","author":"CX Lim","year":"2024","unstructured":"Lim CX, Redl A, Kleissl L, Pandey RV, Mayerhofer C, El Jammal T, Mazic M, Gonzales K, Sukhbaatar N, Krausgruber T, et al. Aberrant lipid metabolism in macrophages is associated with granuloma formation in sarcoidosis. Am J Respir Crit Care Med. 2024;209:1152\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"3863_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000477736","volume":"84","author":"E Bargagli","year":"2017","unstructured":"Bargagli E, Rosi E, Pistolesi M, Lavorini F, Voltolini L, Rottoli P. Increased risk of atherosclerosis in patients with sarcoidosis. Pathobiology. 2017;84:258\u201363.","journal-title":"Pathobiology"},{"key":"3863_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-02084-x","volume":"22","author":"T Suzuki","year":"2022","unstructured":"Suzuki T, Karayama M, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T. Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis. BMC Pulm Med. 2022;22: 290.","journal-title":"BMC Pulm Med"},{"key":"3863_CR25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang JY. Bile acid metabolism and signaling. Compr Physiol. 2013;3:1191\u2013212.","journal-title":"Compr Physiol"},{"key":"3863_CR26","doi-asserted-by":"crossref","unstructured":"Hoss S, Grinberg T, Eisen A. The interrelationship between sarcoidosis and Atherosclerosis-Complex yet rational. J Clin Med. 2022;11:433. https:\/\/www.mdpi.com\/2077-0383\/11\/2\/433.","DOI":"10.3390\/jcm11020433"},{"key":"3863_CR27","doi-asserted-by":"publisher","first-page":"1532437","DOI":"10.3389\/fmed.2025.1532437","volume":"12","author":"T Isshiki","year":"2025","unstructured":"Isshiki T, Sunakawa M, Vierhout M, Ayoub A, Ali P, Naiel S, Miyoshi S, Naqvi A, Hambly N, Kishi K, et al. Upregulation of HSP90alpha in the lungs and circulation in sarcoidosis. Front Med (Lausanne). 2025;12:1532437.","journal-title":"Front Med (Lausanne)"},{"key":"3863_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02907-21","volume":"12","author":"AKP Serquina","year":"2021","unstructured":"Serquina AKP, Tagawa T, Oh D, Mahesh G, Ziegelbauer JM. 25-Hydroxycholesterol inhibits Kaposi\u2019s sarcoma herpesvirus and Epstein-Barr virus infections and activates inflammatory cytokine responses. mBio. 2021;12: e0290721.","journal-title":"mBio"},{"key":"3863_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.1254790","volume":"345","author":"A Reboldi","year":"2014","unstructured":"Reboldi A, Dang EV, McDonald JG, Liang G, Russell DW, Cyster JG. Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science. 2014;345:679\u201384.","journal-title":"Science"},{"key":"3863_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1046\/j.1365-2249.1999.00871.x","volume":"116","author":"YH Huang","year":"1999","unstructured":"Huang YH, Schafer-Elinder L, Wu R, Claesson HE, Frostegard J. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol. 1999;116:326\u201331.","journal-title":"Clin Exp Immunol"},{"key":"3863_CR31","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1182\/blood-2004-05-1916","volume":"105","author":"LV Yang","year":"2005","unstructured":"Yang LV, Radu CG, Wang L, Riedinger M, Witte ON. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood. 2005;105:1127\u201334.","journal-title":"Blood"},{"key":"3863_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.bbrc.2011.10.119","volume":"415","author":"H Hasegawa","year":"2011","unstructured":"Hasegawa H, Lei J, Matsumoto T, Onishi S, Suemori K, Yasukawa M. Lysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-beta production. Biochem Biophys Res Commun. 2011;415:526\u201331.","journal-title":"Biochem Biophys Res Commun"},{"key":"3863_CR33","doi-asserted-by":"crossref","unstructured":"Arcana RI, Crisan-Dabija R, Cernomaz AT, Buculei I, Burlacu A, Zabara ML, Trofor AC. The risk of sarcoidosis misdiagnosis and the harmful effect of corticosteroids when the disease picture is incomplete. Biomedicines. 2023;11:175. https:\/\/www.mdpi.com\/2227-9059\/11\/1\/175.","DOI":"10.3390\/biomedicines11010175"},{"key":"3863_CR34","doi-asserted-by":"publisher","first-page":"103207","DOI":"10.1016\/j.jaut.2024.103207","volume":"149","author":"F Bonella","year":"2024","unstructured":"Bonella F, Dm Vorselaars A, Wilde B. Kidney manifestations of sarcoidosis. J Autoimmun. 2024;149:103207.","journal-title":"J Autoimmun"},{"key":"3863_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.rmed.2008.10.007","volume":"103","author":"AW Boots","year":"2009","unstructured":"Boots AW, Drent M, Swennen EL, Moonen HJ, Bast A, Haenen GR. Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants. Respir Med. 2009;103:364\u201372.","journal-title":"Respir Med"},{"key":"3863_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","volume":"103","author":"S Copur","year":"2022","unstructured":"Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: does uric acid have a definitive role? Eur J Intern Med. 2022;103:4\u201312.","journal-title":"Eur J Intern Med"},{"key":"3863_CR37","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1055\/a-1240-5850","volume":"52","author":"R Isnuwardana","year":"2020","unstructured":"Isnuwardana R, Bijukchhe S, Thadanipon K, Ingsathit A, Thakkinstian A. Association between vitamin D and uric acid in adults: a systematic review and meta-analysis. Horm Metab Res. 2020;52:732\u201341.","journal-title":"Horm Metab Res"},{"key":"3863_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-00560-1","volume":"20","author":"Y Chen","year":"2020","unstructured":"Chen Y, Cheng J, Chen Y, Wang N, Xia F, Chen C, Han B, Lu Y. Association between serum vitamin D and uric acid in the Eastern Chinese population: a population-based cross-sectional study. BMC Endocr Disord. 2020;20: 79.","journal-title":"BMC Endocr Disord"},{"key":"3863_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/er.2016-1070","volume":"37","author":"PJ Tebben","year":"2016","unstructured":"Tebben PJ, Singh RJ, Kumar R. Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev. 2016;37:521\u201347.","journal-title":"Endocr Rev"},{"key":"3863_CR40","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s10157-019-01760-3","volume":"23","author":"N Toriu","year":"2019","unstructured":"Toriu N, Sumida K, Oguro M, Oshima Y, Mizuno H, Hasegawa E, Suwabe T, Kawada M, Ueno T, Hayami N, et al. Increase of 1,25 dihydroxyvitamin D in sarcoidosis patients with renal dysfunction. Clin Exp Nephrol. 2019;23:1202\u201310.","journal-title":"Clin Exp Nephrol"},{"key":"3863_CR41","doi-asserted-by":"publisher","first-page":"181986","DOI":"10.1155\/2015\/181986","volume":"2015","author":"M Bucova","year":"2015","unstructured":"Bucova M, Suchankova M, Tibenska E, Tedlova E, Demian J, Majer I, Novosadova H, Tedla M. TREM-2 Receptor Expression Increases with 25(OH)D Vitamin Serum Levels in Patients with Pulmonary Sarcoidosis. Mediators Inflamm. 2015;2015:181986.","journal-title":"Mediators Inflamm"},{"key":"3863_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003127","author":"E Atlantis","year":"2013","unstructured":"Atlantis E, Fahey P, Cochrane B, Wittert G, Smith S. Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 2013. https:\/\/doi.org\/10.1136\/bmjopen-2013-003127.","journal-title":"BMJ Open"},{"key":"3863_CR43","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/crj.12150","volume":"9","author":"RM Bercea","year":"2015","unstructured":"Bercea RM, Mihaescu T, Cojocaru C, Bjorvatn B. Fatigue and serum testosterone in obstructive sleep apnea patients. Clin Respir J. 2015;9:342\u20139.","journal-title":"Clin Respir J"},{"key":"3863_CR44","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1016\/j.rmed.2007.07.009","volume":"101","author":"MA Spruit","year":"2007","unstructured":"Spruit MA, Thomeer MJ, Gosselink R, Wuyts WA, Van Herck E, Bouillon R, Demedts MG, Decramer M. Hypogonadism in male outpatients with sarcoidosis. Respir Med. 2007;101:2502\u201310.","journal-title":"Respir Med"},{"key":"3863_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1479-5876-10-111","volume":"10","author":"M Shigemura","year":"2012","unstructured":"Shigemura M, Nasuhara Y, Konno S, Shimizu C, Matsuno K, Yamguchi E, Nishimura M. Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis. J Transl Med. 2012;10:111.","journal-title":"J Transl Med"},{"key":"3863_CR46","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1378\/chest.09-1975","volume":"137","author":"S Miyoshi","year":"2010","unstructured":"Miyoshi S, Hamada H, Kadowaki T, Hamaguchi N, Ito R, Irifune K, Higaki J. Comparative evaluation of serum markers in pulmonary sarcoidosis. Chest. 2010;137:1391\u20137.","journal-title":"Chest"},{"key":"3863_CR47","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1378\/chest.109.5.1276","volume":"109","author":"J Kobayashi","year":"1996","unstructured":"Kobayashi J, Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest. 1996;109:1276\u201382.","journal-title":"Chest"},{"key":"3863_CR48","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1378\/chest.124.6.2119","volume":"124","author":"R Janssen","year":"2003","unstructured":"Janssen R, Sato H, Grutters JC, Bernard A, van Velzen-Blad H, du Bois RM, van den Bosch JM. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. Chest. 2003;124:2119\u201325.","journal-title":"Chest"},{"key":"3863_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2796.2006.01704.x","volume":"260","author":"H Satoh","year":"2006","unstructured":"Satoh H, Kurishima K, Ishikawa H, Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med. 2006;260:429\u201334.","journal-title":"J Intern Med"},{"key":"3863_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02524-0","volume":"24","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Chen X, Zhao M, Lower EE, Baughman RP. SACE and IL-2R as serum biomarkers for evaluation of multi-organ involvement and prognosis of sarcoidosis. Respir Res. 2023;24: 219.","journal-title":"Respir Res"},{"key":"3863_CR51","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.rmed.2017.10.006","volume":"138S","author":"VR Parasa","year":"2018","unstructured":"Parasa VR, Forsslund H, Enger T, Lorenz D, Kullberg S, Eklund A, Skold M, Wahlstrom J, Grunewald J, Brighenti S. Enhanced CD8(+) cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-Lofgren\u2019s disease. Respir Med. 2018;138S:S38\u201344.","journal-title":"Respir Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03863-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03863-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03863-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:09:09Z","timestamp":1757333349000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03863-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3863"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03863-y","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the institutional review board of Shanghai Pulmonary Hospital (No. K21-074Z). Written informed consent was obtained from all participants. All procedures were conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}